Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm

Anti-PD1 and anti-PD-L1 agents may have intrinsic and clinically relevant differences in the treatment of non-small cell lung cancer (NSCLC) patients. By reviewing currently available indirect evidence on these agents for NSCLC treatment, highlighting possible inter- and intra-class dissimilarities,...

Descripción completa

Detalles Bibliográficos
Autores principales: Banna, Giuseppe Luigi, Cantale, Ornella, Bersanelli, Melissa, Del Re, Marzia, Friedlaender, Alex, Cortellini, Alessio, Addeo, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385529/
https://www.ncbi.nlm.nih.gov/pubmed/32782728
http://dx.doi.org/10.4081/oncol.2020.490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385529/
https://www.ncbi.nlm.nih.gov/pubmed/32782728
http://dx.doi.org/10.4081/oncol.2020.490

Ejemplares similares